115 related articles for article (PubMed ID: 6329833)
1. [Value of depot synacthen therapy in dermatoses. A report of over 6-years' experiences].
Harnack K; Flegel P
Dermatol Monatsschr; 1984; 170(4):237-43. PubMed ID: 6329833
[No Abstract] [Full Text] [Related]
2. [ACTH therapy of dermatoses].
Schuppli R
Hautarzt; 1977 Jan; 28(1):1-4. PubMed ID: 190189
[No Abstract] [Full Text] [Related]
3. [Use of Cortrosyn Depot in dermatology].
Aussems J
Brux Med; 1976 Jan; 56(1):15-20. PubMed ID: 175889
[No Abstract] [Full Text] [Related]
4. [Synacthen retard].
Ménégol B; Brard M
Soins; 1985 Apr; (451):I-II. PubMed ID: 3008345
[No Abstract] [Full Text] [Related]
5. [Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
John K; Gaida P; Kauf E
Padiatr Grenzgeb; 1985; 24(5):391-9. PubMed ID: 2999679
[No Abstract] [Full Text] [Related]
6. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
Bordier C; Flechet ML; Thomine E; Lauret P
Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
[No Abstract] [Full Text] [Related]
7. [Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].
Roldaan AC; de Jong C
Ned Tijdschr Geneeskd; 1981 Feb; 125(8):321-3. PubMed ID: 6261167
[No Abstract] [Full Text] [Related]
8. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].
Kropp R
Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022
[TBL] [Abstract][Full Text] [Related]
9. [Synthetic ACTH in theumatic diseases: (author's transl)].
Hieber F
MMW Munch Med Wochenschr; 1975 Nov; 117(46):1849-52. PubMed ID: 172785
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.
Glass D; Roffe L; Maini RN; Wraith DG; Nuki G
Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487
[TBL] [Abstract][Full Text] [Related]
11. Corticotrophin and tetracosactrin depot-self-administered for the treatment of eczema.
Munro DD
Br J Dermatol; 1976 Mar; 94 suppl 12():135-8. PubMed ID: 178340
[TBL] [Abstract][Full Text] [Related]
12. Blood oxytocinases and phosphatases levels in pregnant women treated with synacthen-depot.
Klimek R; Krzysiek J; Paradysz A; Stanek J
Endokrynol Pol; 1978; 29(2):121-9. PubMed ID: 207513
[No Abstract] [Full Text] [Related]
13. [Fatal complication of intravenous administration of synthetic adrenocorticotrophin].
Müller M; Fehm HL; Homoki J; Teller WM
Dtsch Med Wochenschr; 1982 Sep; 107(36):1353-6. PubMed ID: 6288339
[TBL] [Abstract][Full Text] [Related]
14. [Synacthen therapy and prostatic carcinoma?].
Staehler W; Ziegler H
Med Welt; 1975 Apr; 26(14):682. PubMed ID: 169454
[No Abstract] [Full Text] [Related]
15. [Tetracosactid (Synacthen) as a therapeutic alternative in uveitis and other chronic inflammations of the eye].
Fricke HJ; Heydenreich A; Thiel U; Schröder D
Klin Monbl Augenheilkd; 1983 Jul; 183(1):10-6. PubMed ID: 6310203
[No Abstract] [Full Text] [Related]
16. [Discussion of a case of dyschromia].
Nicolay M; Piot V
Arch Belg Dermatol; 1974; 30(2):99-101. PubMed ID: 4377809
[No Abstract] [Full Text] [Related]
17. [Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].
Rott Z; Fajt E; Tóth S; Hammer I; Nagy G
Orv Hetil; 1983 Jul; 124(31):1883-6. PubMed ID: 6314223
[No Abstract] [Full Text] [Related]
18. [Tetracosactide in the treatment of rheumatoid arthritis and gout].
Usobiaga JL
Rev Esp Reum Enferm Osteoartic; 1975; 18(2):145-54. PubMed ID: 167406
[No Abstract] [Full Text] [Related]
19. [Synacthene-Retard in mental confusion of aged patients].
Porte M; Juttner G; Michelangeli J; Krebs BP; Lavagna J; Capdeville C; Darcourt G
Ann Med Psychol (Paris); 1979; 137(5):481-90. PubMed ID: 228577
[No Abstract] [Full Text] [Related]
20. West's syndrome and its treatment.
Sorel L
Clin Electroencephalogr; 1985 Jul; 16(3):122-7. PubMed ID: 2994911
[No Abstract] [Full Text] [Related]
[Next] [New Search]